Megan Boston - 13 Jun 2023 Form 4 Insider Report for Benitec Biopharma Inc. (BNTC)

Role
Executive Director, Director
Signature
/s/ Megan Boston
Issuer symbol
BNTC
Transactions as of
13 Jun 2023
Net transactions value
$0
Form type
4
Filing time
15 Jun 2023, 16:13:33 UTC
Next filing
14 Aug 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BNTC Options (right to buy) Award $0 +153,000 $0.000000 153,000 13 Jun 2023 Common Stock 153,000 $0.2300 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options will vest in three substantially equal installments on June 13, 2024, June 13, 2025, and June 13, 2026.